Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis

被引:11
作者
Peterson, Lisa K.
Tsunoda, Ikuo
Masaki, Takahisa
Fujinami, Robert S.
机构
[1] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84132 USA
[2] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA
关键词
autoantibodies; autoimmunity; CNS-demyelinating autoimmune diseases; demyelinating diseases; histology;
D O I
10.1016/j.jneuroim.2006.11.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two myelin oligodendrocyte glycoprotein (MOG(92-106)) monoclonal antibodies (mAbs) were produced from an A.SW mouse with progressive experimental autoimmune encephalomyelitis. Polyreactivity/specificity of the mAbs was demonstrated by ELISA. Functionality and a potential role in pathogenesis of systemic autoimmunity were demonstrated in vitro in a lymphocytotoxicity assay and in vivo upon injection into naive mice. Injection of MOG mAb producing hybridomas into naive mice resulted in immunoglobulin deposition in kidneys and liver. This model will be useful in determining whether transitional forms between CNS (organ)-specific and systemic autoimmune diseases exist, and whether progressive multiple sclerosis has features of a systemic autoimmune disease. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 73 条
  • [1] MULTIPLE-SCLEROSIS AND MYASTHENIA-GRAVIS - CASE-REPORT WITH SINGLE FIBER ELECTROMYOGRAPHY
    ACHARI, AN
    TRONTELJ, JV
    CAMPOS, RJ
    [J]. NEUROLOGY, 1976, 26 (06) : 544 - 546
  • [2] MYASTHENIA-GRAVIS AND MULTIPLE-SCLEROSIS - UNUSUAL COMBINATION OF DISEASES
    AITA, JF
    SNYDER, DH
    REICHL, W
    [J]. NEUROLOGY, 1974, 24 (01) : 72 - 75
  • [3] AMOR S, 1994, J IMMUNOL, V153, P4349
  • [4] Oligodendrocyte-reactive 01, 04, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes
    Asakura, K
    Miller, DJ
    Pogulis, RJ
    Pease, LR
    Rodriguez, M
    [J]. MOLECULAR BRAIN RESEARCH, 1995, 34 (02): : 283 - 293
  • [5] Asakura K, 1998, J NEUROSCI, V18, P7700
  • [6] Barrett L. K., 1970, Metallography, V3, P1, DOI 10.1016/0026-0800(70)90002-9
  • [7] Berger T., 2000, Journal of Neural Transmission Supplement, V60, P351
  • [8] Impaired renal function in progressive multiple sclerosis
    Calabresi, PA
    Austin, H
    Racke, MK
    Goodman, A
    Choyke, P
    Maloni, H
    McFarland, HF
    [J]. NEUROLOGY, 2002, 59 (11) : 1799 - 1801
  • [9] COHEN PL, 2003, FUNDAMENTAL IMMUNOLO, P1371
  • [10] DAAR AS, 1981, CLIN EXP IMMUNOL, V45, P37